Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Psychedelic/Assisted Therapies
Recent news which mentions Psychedelic/Assisted Therapies
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Cybin Delivers Highest Dose Of Psilocybin Analog In Phase 2 For Major Depression
September 21, 2023
Tickers
CYBN
DMTTF
Tags
DMTTF
News
Penny Stocks
From
Benzinga
Enveric Biosciences Nabs U.S. Patent For Novel Psilocybin Derivatives, Details Here
September 21, 2023
Tickers
ENVB
Tags
Market News
Cannabis
Markets
From
Benzinga
Healthcare Providers Can Offer Ketamine Treatment On Employee Insurance Plans
September 20, 2023
Tags
Enthea
Ketamine/Assisted Therapy
News
From
Benzinga
Congress To Discuss New Bill Banning Federal Intervention In States Where Psilocybin Is Legal
September 20, 2023
Tags
News
Cannabis
Market News
From
Benzinga
Kentucky's $42M Ibogaine Budget Plan For Opioid Crisis Hears Testimonies At Second Meeting
September 19, 2023
Tags
Psychedelics
Benzinga
Ibogaine Therapy
From
Benzinga
Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More
September 18, 2023
Tickers
ATAI
CMND
CMPS
DRUG
Tags
Psychedelics
IXHL
CMPS
From
Benzinga
Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic
September 18, 2023
Tickers
MSSTF
Tags
Cannabis
Market News
Markets
From
Benzinga
Billionaire Steve Cohen Invests $19M In Cybin For Psychedelics R&D, Blake Mycoskie's $100M Pledge Update
September 18, 2023
Tickers
ATAI
CYBN
DMTTF
MNMD
Tags
Psychedelic/Assisted Therapies
Legal
Financing
From
Benzinga
Psychedelics Researchers & Industry Leaders Weigh In On Groundbreaking PTSD Treatment News
September 15, 2023
Tickers
NUMIF
Tags
MDMA/assisted therapy
Psychedelics
Benzinga
From
Benzinga
Combining MDMA With Psilocybin Or LSD Could Reduce Difficult Trips, New Study Shows
September 13, 2023
Tickers
MNMD
Tags
Candy Flipping
Imperial College London
MNMD
From
Benzinga
Swedish Foundation Supports Mental Health Innovation With New €3M Psychedelic Science Initiative
September 13, 2023
Tickers
CMPS
Tags
News
Cannabis
Market News
From
Benzinga
Congress Update: House Committee Green Lights Psychedelics Amendments
September 13, 2023
Tags
Markets
federal marijuana reform
Market News
From
Benzinga
NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years
September 12, 2023
Tickers
ATAI
CMPS
CYBN
JAZZ
Tags
CYBN
Psychedelic/Assisted Therapies
Research Nester
From
Benzinga
Michigan Resolution: Veterans Across US Should Have Access To Psychedelic-Assisted Therapy
September 08, 2023
Tags
Psychedelics Reform
Management
Legal
From
Benzinga
'Wolf Of Wall Street' Embraces Ibogaine For Addiction Recovery With Help Of 'Psychedelic Concierge'
September 08, 2023
Tags
Rumors
Psychedelic/Assisted Therapies
Management
From
Benzinga
Optimi Health Will Supply Psychedelics To Canada's SAP, Secures CA$1M Private Financing
September 08, 2023
Tickers
OPTHF
Tags
Management
MDMA Therapy
psilocybin therapies
From
Benzinga
Shaping Federal Policy Around Psychedelic Therapy: APPA Teams Up With Daschle Group
September 07, 2023
Tags
Psychedelic/Assisted Therapies
FDA
The Daschle Group
From
Benzinga
Psychedelics Reform Update: CA Bill's Final Vote, MA 2024 Legalization Ballot, HI Task Force, OR Funding And More
September 07, 2023
Tags
Market News
Cannabis
Markets
From
Benzinga
Johns Hopkins Will Work With Clearmind On Alcohol Addiction Research Program
September 06, 2023
Tickers
CMND
Tags
Global
Next/Generation Psychedelics
Contracts
From
Benzinga
PharmaTher Aims To Mitigate Ketamine Shortage With New FDA Application
September 06, 2023
Tickers
PHRRF
Tags
Psychedelics
Benzinga
Ketamine Treatment
From
Benzinga
Compass Pathways Explores AI-Powered Predictive Model On Psilocybin Therapy For Depression
September 06, 2023
Tickers
CMPS
Tags
News
Guidance
Machine/Learning Research
From
Benzinga
Cybin's Intellectual Powerhouse Grows With New US Patent Covering Deuterated 5-MeO-DMT
September 05, 2023
Tickers
CYBN
DMTTF
Tags
Tryptamines
Deuterated Psychedelics
Benzinga
From
Benzinga
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
September 05, 2023
Tickers
ATAI
BRAXF
CMPS
CYBN
Tags
PSYCF
IXHL
CYBN
From
Benzinga
Sacred Medicine Meets Wall Street: Legal Peyote Company Will Trade On Canadian Market
September 04, 2023
Tags
Legal
Canadian Securities Exchange
Psychedelic/Assisted Therapies
From
Benzinga
Single Psilocybin Dose 'Significantly' Reduces Major Depression Symptoms, New Usona Phase 2 Trial Shows
September 03, 2023
Tags
Psychedelics
Benzinga
Psilocybin program
From
Benzinga
Pete Davidson Reveals He's Tried Ketamine To Cope With Depression
September 01, 2023
Tickers
JNJ
Tags
Pete Davidson
Benzinga
Psychedelics
From
Benzinga
UK Psychedelics Update: MPs Seek Rescheduling, Safe Consumption Sites, OD Prevention Fund
September 01, 2023
Tickers
UK
Tags
Lindus Health
UK Parliament
Psychedelics
From
Benzinga
Colorado's Psychedelic Future Unfolds: Regulators Host Community Meetings To Shape Industry Rules
August 31, 2023
Tags
Regulations
Psychedelics
Benzinga
From
Benzinga
Mindset Pharma's $60M Acquisition, Otsuka's Leap Into Next-Gen Psychiatry Solutions
August 31, 2023
Tickers
CYBN
DMTTF
MSSTF
NUGL
Tags
NUGL
Benzinga
Psychedelics
From
Benzinga
Braxia Scientific Faces Challenges In Accessing Public Market Capital, Reports Q1 Loss
August 31, 2023
Tickers
BRAXF
Tags
Benzinga
Psychedelics
Psychedelic/Assisted Therapies
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.